Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability, and Early Efficacy of Immersive Virtual Reality for Early Neurocognitive Stimulation in the Intensive Care Unit.

NCT03569358 is registered in ClinicalTrials.gov with Changi General Hospital as lead sponsor.

NCT NCT03569358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03569358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability, and Early Efficacy of Immersive Virtual Reality for Early Neurocognitive Stimulation in the Intensive Care Unit.
Lead sponsor
Changi General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 2, 2018
Completion date
July 2, 2019
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium, mechanical ventilation, virtual reality